Evidence map›Paper›PMID 27881410›Full record

ArticleAmerican journal of physiology. Cell physiology2017

TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression.

Amy J Jorgenson, Kyoung Moo Choi, Delphine Sicard, Karry M J Smith, Samantha E Hiemer, Xaralabos Varelas, Daniel J Tschumperlin

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Interpretation of the Yak Skin Single-Cell Transcriptome Landscape.Animals : an open access journal from MDPI · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Combined control of the fibroblast contractile program by YAP and TAZ.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  17. Review
  18. Article
  19. The ECM: To Scaffold, or Not to Scaffold, That Is the Question.International journal of molecular sciences · 2021
    Review
  20. Review
4 · The record

Corrections and comments

  • Commented on by
    2017
5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Amy J JorgensonDepartment of Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, Minnesota; and.
Kyoung Moo ChoiDepartment of Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, Minnesota; and.
Delphine SicardDepartment of Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, Minnesota; and.
Karry M J SmithDepartment of Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, Minnesota; and.
Samantha E HiemerDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts.
Xaralabos VarelasDepartment of Biochemistry, Boston University School of Medicine, Boston, Massachusetts.
Daniel J TschumperlinDepartment of Physiology and Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, Minnesota; and tschumperlin.daniel@mayo.edu.
Mayo Clinic · USBoston University · US

Funding

Mechanobiology of Lung FibrosisR01HL092961 · NHLBI · MAYO CLINIC ROCHESTER · PI Daniel J. Tschumperlin · 2009 to 2026
$8.0M
Defining epithelial polarity cues that direct cell fateR01HL124392 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VARELAS, XARALABOS · 2014 to 2024
$4.5M
Screening Fibroblast-Matrix Stiffness Interactions to ID New Fibrosis TherapiesR21HL113796 · NHLBI · MAYO CLINIC ROCHESTER · PI TSCHUMPERLIN, DANIEL J. · 2013 to 2014
$422k
NHLBI NIH HHS R01 HL092961NHLBI NIH HHS R01 HL124392NHLBI NIH HHS R21 HL113796
6 · The paper itself

Abstract

Recent studies have implicated the Hippo pathway and its transcriptional effectors YAP and TAZ as necessary for fibroblast activation and tissue fibrosis. To test the specific and sufficient roles for TAZ in driving autonomous fibroblast activation, we cultured NIH3T3 fibroblasts expressing a doxycycline-inducible nuclear-localized mutant of TAZ (TAZ4SA) in scaffold-free 3D hanging drop spheroids, or on matrices of specified mechanical rigidity. Control NIH3T3 fibroblasts formed spheroids in hanging drop culture that remained stable and neither increased nor decreased in size significantly over 15 days. In contrast, TAZ4SA-transduced fibroblasts grew robustly in spheroid culture, and expressed enhanced levels of genes encoding profibrotic soluble factors connective tissue growth factor (CTGF), endothelin-1 (Et-1), and plasminogen activator inhibitor 1 (PAI-1). However, TAZ4SA expression was unable to enhance expression of extracellular matrix (ECM)-encoding genes

Indexed as

Paracrine CommunicationAcyltransferasesAnimalsCell ProliferationCells, CulturedExtracellular MatrixExtracellular Matrix ProteinsFibroblastsFibrosisMiceNIH 3T3 CellsSpheroids, CellularTranscriptional ActivationTranscription FactorsAcyltransferasesExtracellular Matrix ProteinsTAFAZZIN protein, humanTranscription Factorscollagenextracellular matrixfibrosisHippostiffness

Identifiers

PMID27881410
PMCPMC5401948
OpenAlexW2556156445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.